|Articles|July 15, 2002
Blue-light damage is well-established risk in pseudophakia
Like most ophthalmologists, I knew little about the significant body of work in the peer-review literature documenting the harmful effects of visible blue-wavelength light on the retina. Because an effective solution to the problem seems to be on the way, the time has come for us to begin to recognize the implications of blue-light exposure in pseudophakic patients.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5
























